General Information of Drug (ID: DM2K6I8)

Drug Name
Ryanodine Drug Info
Synonyms
ryanodine; Ryanodin; 15662-33-6; Ryania; Ryanodol, 3-(1H-pyrrole-2-carboxylate); Ryanadol; (3S,4R,4aR,6S,6aR,7S,8R,8aS,8bR,9S,9aS)-4,6,7,8a,8b,9a-hexahydroxy-7-isopropyl-3,6a,9-trimethyldodecahydro-6,9-methanobenzo[1,2]pentaleno[1,6-bc]furan-8-yl 1H-pyrrole-2-carboxylate; (3S,4R,4aR,6S,6aR,7S,8R,8aS,8bR,9S,9aS)-4,6,7,8a,8b,9a-hexahydroxy-3,6a,9-trimethyl-7-(propan-2-yl)dodecahydro-6,9-methanobenzo[1,2]pentaleno[1,6-bc]furan-8-yl 1H-pyrrole-2-carboxylate; 3-(1H-pyrrole-2-carboxylate; Ryanodine High Purity
Cross-matching ID
PubChem CID
11317883
ChEBI ID
CHEMBL8925
CAS Number
CAS 15662-33-6
TTD Drug ID
D08LUJ

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Ferroptosis -1.72 4.93e-2 36/41 (87.8%) CYBB;PRNP;TP53;...
Collecting duct acid secretion -1.74 4.35e-2 22/27 (81.48%) ATP6V1E1;ATP6V0A4;ATP6V0A1;...
Cocaine addiction -1.74 4.97e-2 42/49 (85.71%) GRIA2;FOSB;ATF4;...
Retinol metabolism -1.78 3.20e-2 41/68 (60.29%) UGT2B28;CYP3A7;UGT2B17;...
Folate biosynthesis -1.85 7.20e-3 23/26 (88.46%) ALPP;MOCS1;TH;...
Protein processing in endoplasmic reticulum -1.87 6.00e-3 127/171 (74.27%) SSR3;EIF2AK1;SEC61B;...
Vibrio cholerae infection -1.87 8.00e-3 44/50 (88%) SEC61B;KDELR2;TJP1;...
N-Glycan biosynthesis -1.91 6.00e-3 38/50 (76%) DDOST;MGAT4A;B4GALT1;...
Mitophagy -2.01 0.00e+0 56/68 (82.35%) CITED2;TBK1;TBC1D15;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 10uM 6H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 10uM 6H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ASC CVCL_U602 Homo sapiens 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 10uM 6H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H, 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 10uM 6H